# Nevirapine

NDC: 33342-004
Generic name: Nevirapine
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190128

FDA application: ANDA090688

## Active ingredients

- NEVIRAPINE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-004"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-004
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=effb86cc-4b80-4fac-aaa3-9f373b3d0f7d